NeoBiotechnologies

NeoBiotechnologies has exclusive rights to over 10,000 highly validated monoclonal and recombinant antibodies for research, diagnostic, and therapeutic use. We design and develop our own antibodies, we are not a reseller, and our impressive development pipeline launches 500 new, fully-validated monoclonal antibodies each year. Our antibodies are available for direct sale to users, distribution, OEM, licensing, and bulk/custom orders. Message us or visit our website if you would like to learn more. NeoBiotechnologies is an established biotechnology company in Silicon Valley. For the past decade, we have been supplying our reagents to scientists, research institutions, and other large antibody companies worldwide and pride ourselves in being able to support life sciences research through our products. We are unique in the industry as we are one of the few original manufacturers of antibodies, not a reseller, and as such are able to ship products the next business day. Bulk orders or custom formulations are readily supported as we develop our own products and are not dependent on third party suppliers. Our products are tested for Immunohistochemistry (IHC) applications, Western Blot, Flow Cytometry, and Immunofluorescence (IF). Many of our products go through additional rigorous validation to ensure monospecificity, using tissue microarrays to test on a variety of tissues and advanced protein arrays containing 21,000 human proteins. We engage in out-licensing, in-licensing, and partnerships and welcome the opportunity to collaborate together.

网站

https://www.neobiotechnologies.com/

NeoBiotechnologies的外部链接

所属行业

生物技术研究

规模

11-50 人

总部

Union City，California

类型

私人持股

创立

2013

领域

antibodies、proteins、cell lines、rabbit antibodies、immunoassays、ELISA kits、biological reagents、monoclonal antibodies、research、drug discovery、diagnostics、RabMAb、Life Sciences、Cancer diagnostics、Immunohistochemistry (IHC)、Flow Cytometry、immuno-oncology和recombinant antibodies